Tacrolimus therapy for refractory renal allograft rejection: Experience with steroid withdrawal

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 307-

  Cronin II, D C ^a   Bruce, D S ^a   Newell, K A ^a   Josephson, M A ^a   Millis, J M ^a   Piper, J B ^a   Ruebe, M ^a   Kirby, M ^a   Thistlethwaite Jr , J R ^a   Woodle, E S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; OKT 3; PREDNISONE; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG WITHDRAWAL; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; PRIORITY JOURNAL; STEROID THERAPY;

ADULT; ANTILYMPHOCYTE SERUM; CREATININE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MUROMONAB-CD3; PREDNISONE; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 12644273808     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00273-4     Document Type: Conference Paper

References (3)

1. Jordan ML, Shapiro R, Vivas C, et al: Transplantation 57:860, 1994
2. Woodle ES, Perdrizet GA, So SKS. et al: Clin Transplant 9:45, 1995
3. Woodle ES, Josephson M, Newell KA, et al: Clin Transplant (in press)